Atlas Trials

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Clinical trial NCT05245903 · RECRUITING

Trial details

NCT number
NCT05245903
Sponsor
Mclean Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Alzheimer DiseaseDementia AlzheimersDementiaCognitive ImpairmentMild Cognitive ImpairmentNeurodegenerative DiseasesNeurocognitive DisordersNeurocognitive DysfunctionCognitive DysfunctionMental Disorder
Start date
2022-05-31
Primary completion
2026-05-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.